Alto Neuroscience Inc. (NYSE: ANRO) Stock Information | RedChip

Alto Neuroscience Inc. (NYSE: ANRO)


$4.5100
+0.0700 ( -1.53% ) 57.8K

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Market Data


Open


$4.5100

Previous close


$4.4400

Volume


57.8K

Market cap


$120.56M

Day range


$4.3520 - $4.6200

52 week range


$3.5600 - $24.0000

SEC Filings


Form Type Description Pages Date
3 Insider transactions 1 Feb 01, 2024
3 Insider transactions 2 Feb 01, 2024
3 Insider transactions 2 Feb 01, 2024
3 Insider transactions 2 Feb 01, 2024
3 Insider transactions 2 Feb 01, 2024
3 Insider transactions 1 Feb 01, 2024
3 Insider transactions 2 Feb 01, 2024
3 Insider transactions 2 Feb 01, 2024
3 Insider transactions 2 Feb 01, 2024
3 Insider transactions 2 Feb 01, 2024

Latest News